|
1
|
Barton MK: Patients of all ages with
advanced non-small cell lung cancer are not receiving chemotherapy.
CA Cancer J Clin. 65:337–338. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hou M, Cheng Z, Shen H, He S, Li Y, Pan Y,
Feng C, Chen X, Zhang Y, Lin M, et al: High expression of CTHRC1
promotes EMT of epithelial ovarian cancer (EOC) and is associated
with poor prognosis. Oncotarget. 6:35813–35829. 2015.PubMed/NCBI
|
|
4
|
Micalizzi DS, Farabaugh SM and Ford HL:
Epithelial-mesenchymal transition in cancer: Parallels between
normal development and tumor progression. J Mammary Gland Biol
Neoplasia. 15:117–134. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ma L, Teruya-Feldstein J and Weinberg RA:
Tumour invasion and metastasis initiated by microRNA-10b in breast
cancer. Nature. 449:682–688. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Iwatsuki M, Mimori K, Yokobori T, Ishi H,
Beppu T, Nakamori S, Baba H and Mori M: Epithelial-mesenchymal
transition in cancer development and its clinical significance.
Cancer Sci. 101:293–299. 2010. View Article : Google Scholar
|
|
7
|
Kim YJ, Choi WI, Jeon BN, Choi KC, Kim K,
Kim TJ, Ham J, Jang HJ, Kang KS and Ko H: Stereospecific effects of
ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal
transition and suppresses lung cancer migration, invasion and
anoikis resistance. Toxicology. 322:23–33. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cichon MA and Radisky DC: ROS-induced
epithelial-mesenchymal transition in mammary epithelial cells is
mediated by NF-κB-dependent activation of Snail. Oncotarget.
5:2827–2838. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kim J, Moon SH, Kim BT, Chae CH, Lee JY
and Kim SH: A novel aminothiazole KY-05009 with potential to
inhibit Traf2-and Nck-interacting kinase (TNIK) attenuates
TGF-β1-mediated epithelial-to-mesenchymal transition in human lung
adenocarcinoma A549 cells. PLoS One. 9:e1101802014. View Article : Google Scholar
|
|
10
|
Fong YC, Hsu SF, Wu CL, Li TM, Kao ST,
Tsai FJ, Chen WC, Liu SC, Wu CM and Tang CH: Transforming growth
factor-beta1 increases cell migration and beta1 integrin
up-regulation in human lung cancer cells. Lung Cancer. 64:13–21.
2009. View Article : Google Scholar
|
|
11
|
Ko H: Geraniin inhibits TGF-β1-induced
epithelial-mesenchymal transition and suppresses A549 lung cancer
migration, invasion and anoikis resistance. Bioorg Med Chem Lett.
25:3529–3534. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nogata Y, Sakamoto K, Shiratsuchi H, Ishii
T, Yano M and Ohta H: Flavonoid composition of fruit tissues of
citrus species. Biosci Biotechnol Biochem. 70:178–192. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lee YC, Cheng TH, Lee JS, Chen JH, Liao
YC, Fong Y, Wu CH and Shih YW: Nobiletin, a citrus flavonoid,
suppresses invasion and migration involving FAK/PI3K/Akt and small
GTPase signals in human gastric adenocarcinoma AGS cells. Mol Cell
Biochem. 347:103–115. 2011. View Article : Google Scholar
|
|
14
|
Baek SH, Kim SM, Nam D, Lee JH and Ahn KS,
Choi SH, Kim SH, Shim BS, Chang IM and Ahn KS: Antimetastatic
effect of nobiletin through the down-regulation of CXC chemokine
receptor type 4 and matrix metallopeptidase-9. Pharm Biol.
50:1210–1218. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gao XJ, Liu JW, Zhang QG, Zhang JJ, Xu HT
and Liu HJ: Nobiletin inhibited hypoxia-induced
epithelial-mesenchymal transition of lung cancer cells by
inactivating of Notch-1 signaling and switching on miR-200b.
Pharmazie. 70:256–262. 2015.PubMed/NCBI
|
|
16
|
Song J, Shu L, Zhang Z, Tan X, Sun E, Jin
X, Chen Y and Jia X: Reactive oxygen species-mediated mitochondrial
pathway is involved in Baohuoside I-induced apoptosis in human
non-small cell lung cancer. Chem Biol Interact. 199:9–17. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang M, Xie X and Ding Y: SALL4 is a
marker of poor prognosis in serous ovarian carcinoma promoting
invasion and metastasis. Oncol Rep. 35:1796–1806. 2016.PubMed/NCBI
|
|
18
|
Smith AL, Robin TP and Ford HL: Molecular
pathways: Targeting the TGF-β pathway for cancer therapy. Clin
Cancer Res. 18:4514–4521. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Moustakas A and Heldin CH: Signaling
networks guiding epithelial-mesenchymal transitions during
embryogenesis and cancer progression. Cancer Sci. 98:1512–1520.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Puisieux A, Brabletz T and Caramel J:
Oncogenic roles of EMT-inducing transcription factors. Nat Cell
Biol. 16:488–494. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shi Y, Wu H, Zhang M, Ding L, Meng F and
Fan X: Expression of the epithelial-mesenchymal transition-related
proteins and their clinical significance in lung adenocarcinoma.
Diagn Pathol. 8:892013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bolós V, Peinado H, Pérez-Moreno MA, Fraga
MF, Esteller M and Cano A: The transcription factor Slug represses
E-cadherin expression and induces epithelial to mesenchymal
transitions: A comparison with Snail and E47 repressors. J Cell
Sci. 116:499–511. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kim J and Hwan Kim S: CK2 inhibitor
CX-4945 blocks TGF-β1-induced epithelial-to-mesenchymal transition
in A549 human lung adenocarcinoma cells. PLoS One. 8:e743422013.
View Article : Google Scholar
|
|
24
|
Hoot KE, Lighthall J, Han G, Lu SL, Li A,
Ju W, Kulesz-Martin M, Bottinger E and Wang XJ:
Keratinocyte-specific Smad2 ablation results in increased
epithelial-mesenchymal transition during skin cancer formation and
progression. J Clin Invest. 118:2722–2732. 2008.PubMed/NCBI
|
|
25
|
Chien SY, Hsieh MJ, Chen CJ, Yang SF and
Chen MK: Nobiletin inhibits invasion and migration of human
nasopharyngeal carcinoma cell lines by involving ERK1/2 and
transcriptional inhibition of MMP-2. Expert Opin Ther Targets.
19:307–320. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sato T, Koike L, Miyata Y, Hirata M,
Mimaki Y, Sashida Y, Yano M and Ito A: Inhibition of activator
protein-1 binding activity and phosphatidylinositol 3-kinase
pathway by nobiletin, a polymethoxy flavonoid, results in
augmentation of tissue inhibitor of metalloproteinases-1 production
and suppression of production of matrix metalloproteinases-1 and -9
in human fibrosarcoma HT-1080 cells. Cancer Res. 62:1025–1029.
2002.PubMed/NCBI
|
|
27
|
De Craene B and Berx G: Regulatory
networks defining EMT during cancer initiation and progression. Nat
Rev Cancer. 13:97–110. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Su BH, Tseng YL, Shieh GS, Chen YC, Wu P,
Shiau AL and Wu C: Overexpression of prothymosin α antagonizes
TGF-β signalling to promote the development of emphysema. J Pathol.
238:412–422. 2015. View Article : Google Scholar
|
|
29
|
Dayer C and Stamenkovic I: Recruitment of
matrix metal-loproteinase-9 (MMP-9) to the fibroblast cell surface
by lysyl hydroxylase 3 (LH3) triggers transforming growth factor-β
(TGF-β) activation and fibroblast differentiation. J Biol Chem.
290:13763–13778. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cicchini C, Laudadio I, Citarella F,
Corazzari M, Steindler C, Conigliaro A, Fantoni A, Amicone L and
Tripodi M: TGFbeta-induced EMT requires focal adhesion kinase (FAK)
signaling. Exp Cell Res. 314:143–152. 2008. View Article : Google Scholar
|
|
31
|
Baquero P, Jiménez-Mora E, Santos A, Lasa
M and Chiloeches A: TGFβ induces epithelial-mesenchymal transition
of thyroid cancer cells by both the BRAF/MEK/ERK and Src/FAK
pathways. Mol Carcinog. Sep 21–2015.Epub ahead of print. View Article : Google Scholar
|
|
32
|
Guarino M: Src signaling in cancer
invasion. J Cell Physiol. 223:14–26. 2010.PubMed/NCBI
|
|
33
|
Frame MC and Inman GJ: NCAM is at the
heart of reciprocal regulation of E-cadherin- and integrin-mediated
adhesions via signaling modulation. Dev Cell. 15:494–496. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jagadeeswaran R, Surawska H, Krishnaswamy
S, Janamanchi V, Mackinnon AC, Seiwert TY, Loganathan S, Kanteti R,
Reichman T, Nallasura V, et al: Paxillin is a target for somatic
mutations in lung cancer: Implications for cell growth and
invasion. Cancer Res. 68:132–142. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Nagathihalli NS and Merchant NB:
Src-mediated regulation of E-cadherin and EMT in pancreatic cancer.
Front Biosci. 17:2059–2069. 2012. View
Article : Google Scholar
|
|
36
|
Wilson C, Nicholes K, Bustos D, Lin E,
Song Q, Stephan JP, Kirkpatrick DS and Settleman J: Overcoming
EMT-associated resistance to anti-cancer drugs via Src/FAK pathway
inhibition. Oncotarget. 5:7328–7341. 2014. View Article : Google Scholar : PubMed/NCBI
|
